Thanks. It's good to know that it also acts upon vascular tissues as well. Not good.
However, concentration as a defense makes sense but the implication of tissue interaction at all when most of the media spits "it only interacts with the immune system tee hee" is not a good look at all.
The case for concentration influence also should be looked at further toward interactions with those of more-rare cases wherein that the lower concentration would effect them due to previous medical issues, drug interaction, or genetic defect would play a part.
Same idea as aspirin is fine in low doses, but there are some people who shouldn't even be exposed to a low dose because of previous conditions or other interactions that can lead to an influence of the drug that isn't seen in all of the population.
Even then, we don't even know how concentration ramps up within the human body overtime yet as studies haven't even exceed a year of clinical trial yet. Who is to say production wouldn't increase overtime or when exposed to a certain vector?
It's shit like this that requires clinical studies to be 10 years minimum. Too many unknown variables we're still testing for. A month ago nobody would have known of this stuff, but here it is and we're already trying to justify it.